X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with RELAXO FOOTWEARS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs RELAXO FOOTWEARS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES RELAXO FOOTWEARS AMAR REMEDIES/
RELAXO FOOTWEARS
 
P/E (TTM) x -0.5 56.7 - View Chart
P/BV x 0.1 13.1 0.5% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 AMAR REMEDIES   RELAXO FOOTWEARS
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
RELAXO FOOTWEARS
Mar-18
AMAR REMEDIES/
RELAXO FOOTWEARS
5-Yr Chart
Click to enlarge
High Rs164724 22.7%   
Low Rs86447 19.2%   
Sales per share (Unadj.) Rs261.6162.6 160.9%  
Earnings per share (Unadj.) Rs17.413.4 130.0%  
Cash flow per share (Unadj.) Rs22.317.9 124.5%  
Dividends per share (Unadj.) Rs01.50 0.0%  
Dividend yield (eoy) %00.3 0.0%  
Book value per share (Unadj.) Rs100.763.2 159.3%  
Shares outstanding (eoy) m26.16120.35 21.7%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.53.6 13.3%   
Avg P/E ratio x7.243.7 16.4%  
P/CF ratio (eoy) x5.632.7 17.2%  
Price / Book Value ratio x1.29.3 13.4%  
Dividend payout %011.2 0.0%   
Avg Mkt Cap Rs m3,27070,423 4.6%   
No. of employees `000NA5.7 0.0%   
Total wages/salary Rs m1632,141 7.6%   
Avg. sales/employee Rs ThNM3,410.5-  
Avg. wages/employee Rs ThNM373.1-  
Avg. net profit/employee Rs ThNM280.7-  
INCOME DATA
Net Sales Rs m6,84419,569 35.0%  
Other income Rs m2145 47.1%   
Total revenues Rs m6,86519,614 35.0%   
Gross profit Rs m1,1313,021 37.4%  
Depreciation Rs m128543 23.6%   
Interest Rs m39886 463.3%   
Profit before tax Rs m6262,436 25.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m121826 14.7%   
Profit after tax Rs m4551,611 28.2%  
Gross profit margin %16.515.4 107.1%  
Effective tax rate %19.333.9 57.0%   
Net profit margin %6.68.2 80.8%  
BALANCE SHEET DATA
Current assets Rs m4,9045,806 84.5%   
Current liabilities Rs m3,5814,335 82.6%   
Net working cap to sales %19.37.5 257.1%  
Current ratio x1.41.3 102.2%  
Inventory Days Days12459 212.2%  
Debtors Days Days10036 279.2%  
Net fixed assets Rs m1,6896,624 25.5%   
Share capital Rs m262120 217.8%   
"Free" reserves Rs m2,3587,492 31.5%   
Net worth Rs m2,6357,612 34.6%   
Long term debt Rs m507393 129.1%   
Total assets Rs m6,86212,687 54.1%  
Interest coverage x2.629.4 8.8%   
Debt to equity ratio x0.20.1 373.1%  
Sales to assets ratio x1.01.5 64.7%   
Return on assets %12.413.4 93.0%  
Return on equity %17.321.2 81.6%  
Return on capital %31.031.5 98.4%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m273456 59.8%   
Fx outflow Rs m23,120 0.1%   
Net fx Rs m271-2,664 -10.2%   
CASH FLOW
From Operations Rs m-3131,543 -20.3%  
From Investments Rs m-489-1,084 45.1%  
From Financial Activity Rs m769-463 -166.1%  
Net Cashflow Rs m-33-4 833.3%  

Share Holding

Indian Promoters % 25.5 75.0 34.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 9.2 0.0 -  
FIIs % 0.0 1.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 23.9 273.2%  
Shareholders   13,061 3,357 389.1%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   GODREJ INDUSTRIES  JYOTHY LABS  P&G HYGIENE  MARICO  BATA INDIA  

Compare AMAR REMEDIES With:   UNILEVER PLC. (UK)  P&G (US)  HYPERMARCAS (Brazil)  



Today's Market

Indian Indices End on a Strong Note; Sensex Ends 489 Points Higher(Closing)

After opening the day marginally lower, Indian share markets witnessed most of the buying interest during closing hours and ended their trading session on a strong note.

Related Views on News

RELAXO FOOTWEARS Plunges by 7%; BSE 500 Index Down 0.2% (Market Updates)

Jun 20, 2019 | Updated on Jun 20, 2019

RELAXO FOOTWEARS share price has plunged by 7% and its current market price is Rs 777. The BSE 500 is down by 0.2%. The top gainers in the BSE 500 Index are TRENT LTD (up 4.8%) and SYMPHONY (up 3.8%). The top losers are RELAXO FOOTWEARS (down 6.9%) and DILIP BUILDCON LTD (down 7.6%).

RELIANCE CAPITAL Plunges by 5%; BSE 500 Index Down 0.2% (Market Updates)

Jun 20, 2019 | Updated on Jun 20, 2019

RELIANCE CAPITAL share price has plunged by 5% and its current market price is Rs 51. The BSE 500 is down by 0.2%. The top gainers in the BSE 500 Index are TRENT LTD (up 4.8%) and SYMPHONY (up 3.8%). The top losers are RELIANCE CAPITAL (down 5.1%) and RELAXO FOOTWEARS (down 6.9%).

HSIL LTD Plunges by 6%; BSE 500 Index Down 0.1% (Market Updates)

Jun 20, 2019 | Updated on Jun 20, 2019

HSIL LTD share price has plunged by 6% and its current market price is Rs 255. The BSE 500 is down by 0.1%. The top gainers in the BSE 500 Index are TRENT LTD (up 4.8%) and SYMPHONY (up 3.8%). The top losers are HSIL LTD (down 5.6%) and RELAXO FOOTWEARS (down 6.9%).

HEIDELBERG CEMENT Plunges by 5%; BSE 500 Index Down 0.1% (Market Updates)

Jun 20, 2019 | Updated on Jun 20, 2019

HEIDELBERG CEMENT share price has plunged by 5% and its current market price is Rs 196. The BSE 500 is down by 0.1%. The top gainers in the BSE 500 Index are TRENT LTD (up 4.8%) and SYMPHONY (up 3.8%). The top losers are HEIDELBERG CEMENT (down 5.1%) and RELAXO FOOTWEARS (down 6.9%).

RELAXO FOOTWEARS Announces Quarterly Results (4QFY19); Net Profit Up 1.8% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, RELAXO FOOTWEARS has posted a net profit of Rs 544 m (up 1.8% YoY). Sales on the other hand came in at Rs 6 bn (up 14.2% YoY). Read on for a complete analysis of RELAXO FOOTWEARS's quarterly results.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

Why I Believe Smallcaps Will Catch up to the Sensex(Profit Hunter)

Jun 14, 2019

Smallcaps have gone nowhere even as the Sensex makes new all-time highs. Find out why Richa believes this a good opportunity to invest in smallcaps.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES - KARUTURI GLOBAL COMPARISON

COMPARE AMAR REMEDIES WITH

MARKET STATS